Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of JP-1366 in patients with erosive gastroesophageal reflux disease (GERD) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• JP-1366

Snippet

Sponsor: Onconic Therapeutics Inc. | Conditions: GERD | Phase 2 | Status: COMPLETED